Dr. Anatoly Dritschilo remains Chairman of the Board and Co-CEO overseeing scientific and clinical trial activitiesGAITHERSBURG, Md., March 12, 2025 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and...
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
WINTER SPRINGS, Fla., March 10, 2025 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that it will participate in the 37th Annual Roth Conference. Iradimed's CFO, Jack Glenn, and CCO, Jeff Chiprin, will host one-on-one meetings between company...
Precision Optics Appoints Buell Duncan to Board of Directors; Dr. Richard Miles Retires from Board
GARDNER, Mass., March 04, 2025 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, is pleased to announce the appointment of Buell Duncan to its...
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024
Full Year 2024 vs. Full Year 2023: Record Net Revenues: $134.9 million, a 7% increase Patient Services Revenue: $80.4 million - Device Solutions Revenue: $54.5 million, increases of 5% and 11% Adjusted EBITDA (non-GAAP): $25.3 million, a 13% increase Record Operating...
Shuttle Pharma Provides Corporate Update and Reports 2024 Results
GAITHERSBURG, Md., Feb. 26, 2025 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation...
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024
PORTLAND, Maine, Feb. 25, 2025 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
Precision Optics Announces Closing of $5.1 Million Offering of Common Stock to Fund Business Expansion
GARDNER, Mass., Feb. 24, 2025 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries today announced the closing of its registered direct offering of...
Dror Successfully Completes User Experience Trial of its new ZSmile Platform
JERUSALEM, Feb. 24, 2025 -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), a pioneer in AI-powered orthodontic solutions, today announced the successful completion of user experience trials for its ZSmile platform ahead of its commercial release....
Precision Optics Announces Pricing of $5.1 Million Offering of Common Stock to Fund Business Expansion
GARDNER, Mass., Feb. 20, 2025 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has entered into securities purchase...